3SBio, Selecta join hands to develop gout therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2014
Singapore: China based biotech firm, 3SBio, has partnered with Selecta Biosciences to license out pegsiticase (Uricase P...Read more
Patrys begins multiple myeloma trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2012
Singapore: Patrys, an Australian clinical stage biopharmaceutical company, has completed the initial treatment of the fi...Read more
GVK, Onconova to develop cancer drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2013
Singapore: GVK Bio and US-based Onconova Therapeutics entered into a novel joint partnership to develop new drugs for c...Read more
Myeloma Network raises cancer awareness
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Mar, 2013
Singapore: Asian Myeloma Network is developing a regional collaboration of medical specialists across Asia to study the ...Read more
Novo Nordisk announces trial data of NovoMix 30
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2012
Bangalore: New data from a subgroup analysis of the A1chieve study showed that intensifying treatment with NovoMix 30 (B...Read more
Boehringer starts phase III leukaemia study
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Mar, 2013
Singapore: Boehringer Ingelheim has initiated phase III study (POLO-AML-2) investigating volasertib, a selective and pot...Read more
Takeda resubmits NDA to the US FDA for alogliptin
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 30 Jul, 2012
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...Read more
Phylogica achieves research milestone
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: Phylogica, a public Australian peptide drug discovery company, has achieved a research milestone under its co...Read more
Gilead's angina drug shows +ve result in diabetics
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2013
Singapore: Gilead Sciences has successfully progressed phase IV Terisa (Type 2 Diabetes Evaluation of Ranolazine in subj...Read more
AstraZeneca to integrate dendrimer drug delivery technology in oncology portfolio
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Apr, 2014
Singapore: Global Pharmaceutical company, AstraZeneca plans to integrate Dendrimer drug delivery technology developed by...Read more
Mundipharma to develop cancer pain patch for German firm
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Apr, 2014
Singapore: Mundipharma, global pharmaceutical company with operations in Singapore, has entered into a license agreement...Read more
TNI Biotech, Hubei Qianjian to develop cancer drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Oct, 2012
Singapore: TNI BioTech and Hubei Qianjiang Pharmaceutical, a leading Chinese pharmaceutical company will co-develop new...Read more
Evotec, Debiopharm ink drug discovey alliance
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2014
Singapore: Drug Discovery company, Evotec has inked a research collaboration and licensing deal with Swiss Pharma compan...Read more
Aus, Canada study find how diabetes drug metformin works
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Nov, 2013
Singapore: Researchers from St Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with re...Read more
Agilent LC/MS for 'dried blood-spot analysis'
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 May, 2012
Singapore: Agilent Technologies has introduced the Agilent Automated Card Extraction LC/MS system, a fully integrated in...Read more
AMRI to acquire Cedarburg Pharmaceuticals at $38.2 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2014
Singapore: AMRI has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals for...Read more
Let's make India known for innovations'
Drug Discovery | Opinion | By BioSpectrum Bureau | 0 Comment | 25 Mar, 2014
As a scientist-turned entrepreneur, my journey has taken a long time, with many struggles along the way. For an entrepre...Read more
Novartis gets FDA approval for chronic idiopathic urticaria drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Mar, 2014
Singapore: US Food and Drug Administration (FDA) has approved Novartis' Xolair (omalizumab) for the treatment of chronic...Read more